- Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)
- Tyra Biosciences to Present at Upcoming Investor Conferences
- Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
- Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
Key statistics
On Friday, Tyra Biosciences Inc (TYRA:NSQ) closed at 17.10, -19.11% below its 52-week high of 21.14, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.97 |
---|---|
High | 17.16 |
Low | 16.55 |
Bid | -- |
Offer | -- |
Previous close | 16.97 |
Average volume | 281.11k |
---|---|
Shares outstanding | 52.54m |
Free float | 49.40m |
P/E (TTM) | -- |
Market cap | 898.43m USD |
EPS (TTM) | -1.68 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼